Leading The Future of Biological Electronics
Right pressure is vital to life
InVivo Bionics develops micro and nanotechnology based in vivo pressure sensor systems for continuous monitoring of human organ function. Our vision is to replace biological defects with electronics in vivo.
In the human body, having the right pressure is vital to life. Elevated or low pressure can result in organ failure and in worst-case scenarios, cause death. Examples are heart failure, cardiac infarction, stroke, glaucoma, and urinary bladder dysfunction. Key to preventing these failures is the ability to monitor pressure critical to healthy bodily functions. Existing measurement technologies have several limitations; the pressure measured is only a snapshot of the pressure the body is experiencing, the device can influence the actual measurement and the measurement is often done remotely as with the measurements of bladder and blood pressure.
InVivo Bionics has, in partnership with SINTEF, developed an advanced nanotechnology in vivo sensor system for measurement of pressure directly in organs and other parts of the body. Utilizing our patented pending nanotechnology, InVivo Bionics has developed an extremely small implant sensor that is easy to insert and able to detect a pressure change in key areas in the body on a continuous basis. This sensor, with little discomfort to patients, allows the healthcare professional to gather crucial detailed organ measurements quickly and easily. In addition, the patient’s pressure data can be saved and analyzed, providing valuable feedback for advancing patient care and quality of life while reducing costs. When combined with biofeedback, patience’s with reduced sensory ability can now be trained to restore the lost sensation, often improving dramatically their quality of life.
InVivo Bionics is creating exciting new breakthroughs in nanotechnology within healthcare for healthcare professional and patient care.
InVivo Bionics' first area of focus is the loss of bladder control affecting millions of men and women worldwide and is expected to increase with the rising incidents of diabetes, bladder cancer, and elder boom. Our innovative, wearable solution has already been tested in patients with dysfunctional urinary bladder with great success.
Founder, CEO & CTO
Ingelin holds a Master in Physics from the Norwegian University of Science and Technology and a PhD in physical electronics and semiconductor physics from the University of Oslo. Ingelin has more than 15 years in leading RDI of sensor systems for medical applications. The past 13 years she has been with SINTEF Microsystems and Nanotechology, one of the world top leaders in silicon pressure sensors. Ingelin is experienced in QM and regulatory work. She is currently leading "Future Research Lines" in the ENIUS network http://enius.org/
Trygve graduated from University in Oslo. He is medical specialist in general surgery and urology. Trygve has been chairman of the Norwegian Urological Society. The last 30 years he has been consultant urological surgeon at Rikshospitalet, Oslo University Hospital. His main interest is in the fields of neurourology and reconstructive urology. Trygve has participated in several medical studies and has experience from medical work in different African countries and Middle East.
Per G. Gløersen
Per is a graduated engineer from Norwegian University of Science and Technology and holds a PhD from University of California, Berkeley. Per has vast experience from sensor industry and microelectronics industry (e.g. HP Laboratories in Palo Alto (USA), Vingmed Sound and SensoNor (Norway)). He was co-founder of Getech, has held a number of board positions and also worked as a consultant.
Biomedical Engineer, Multi-entrepreneur
Svein is founder and owner of Vitacon, "The Bladder Scan Company", a global supplier of ultrasonic bladder monitoring systems. Svein brings on board detailed knowledge and competence on markets, market introduction, and production of medical devices. Through Vitacon, he also brings in a global network of suppliers.